Visualization of β-adrenoceptors using PET

Clinical Positron Imaging (Netherlands)

Volumn 1, Issue 2, 1998, Pages 81-94

  Elsinga, Philip H ^a   Van Waarde, Aren ^a   Visser, Ton J ^a   Vaalburg, Willem ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Brain; Carazolol; CGP 12177; CGP 12388; Formoterol; Heart; Lung; PET; Review; adrenoceptor

Indexed keywords

EID: 0002364826     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(98)00002-8     Document Type: Review

References (115)

1. M. Bohm D. Beuckelmann L. Brown G. Feiler B. Lorenz M. Nabauer B. Kemkes E. Erdmann Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium Eur. Heart J. 9 1988 844 852
2. M.B. Fowler J.A. Laser G.L. Hopkins W. Minobe M.R. Bristow Assessment of the beta-adrenergic receptor pathway in the intact failing human heart progressive receptor down-regulation and subsensitivity to agonist response Circulation 74 1986 1290 1302
3. 1-receptor down-regulation in heart failure Circ. Res. 59 1986 297 309
4. 2-adrenoceptors Eur. Heart J. 10 Suppl.B 1989 38 44
5. F.L. Anderson J.D. Port B.B. Reid P. Larrabee G. Hanson M.R. Bristow Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with β-adrenergic receptor downregulation Circulation 85 1992 46 53
6. 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease J. Am. Coll. Cardiol. 14 1989 323 331
7. A.A. Lopes M.H. Liberato M.M. Brentani V.D. Aiello A.A. Riso M. Ebaid Lung beta-adrenoceptors in pulmonary hypertension. A study of biopsy specimens in children with congenital heart disease Chest 99 1991 637 641
8. M.C. Michel T. Philipp O.E. Brodde Alpha- and beta-adrenoceptors in hypertension molecular biology and pharmacological studies Pharmacol. Toxicol. 70 6 Pt 2 1992 S1 S10
9. T. Inukai I. Kobayashi T. Kobayashi A. Ishii T. Yamaguchi Y. Yamaguchi A Iwashita Y. Shimomura S. Kobayashi Parasympathetic nervous system in patients with Graves’ disease determined by R-R interval variations on electrocardiogram Exp. Clin. Endocrinol. 96 1990 289 295
10. A. Basso V. Veccia N. Masera L. Piantanelli Delayed recovery of lymphocyte β-adrenoceptors in thyroidectomized aging patients Gerontology 39 1993 327 333
11. T.F. Bai Beta 2 adrenergic receptors in asthma a current perspective Lung 170 1992 125 141
12. T.R. Bai J.C. Mak P.J. Barnes A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle Am. J. Respir. Cell Mol. Bio. 6 1992 647 651
13. J.A. Raaijmakers C. Beneker R. Dol A.L. de Ruiter Bootsma Decreased bronchiolar epithelial beta-adrenoceptor densities in patients with chronic obstructive lung disease Cell Mol. Biol. 33 1987 515 518
14. 2-adrenergic receptors desensitize in response to in vivo administered β-agonist Am J. Physiol. 269 1995 L709 L714
15. V. De Paermentier S.C. Cheetham M.R. Crompton C.L. Katona R.W. Horton Brain beta-adrenoceptor binding sites in depressed suicide victims effects of antidepressant treatment Psychopharmacology 105 1991 283 288
16. F. De Paermentier M.R. Crompton C.L. Katona R.W. Horton Beta-adrenoceptors in brain and pineal from depressed suicide victims Pharmacol. Toxicol. 71 Suppl 1 1992 86 95
17. A.M. Lands A. Arnold P. McAuliff F.P. Luduena T.G. Brown Differentiation of receptor systems activated by sympathomimetic amines Nature 214 1967 597 598
18. Watson, S.; Abbott, A. TiPS receptor nomenclature supplement. Trends Pharmacol. Sci. (Suppl)1–30; 1990.
19. A.J. Kaumann P. Molenaar Modulation of human cardiac function through four beta-adrenoceptor populations Naunyn-Schmiedebergs Arch. Pharmacol. 355 1997 667 691
20. G. Scatchard The attraction of proteins for small molecules and ions Ann. N.Y. Acad. Sci. 51 1949 660 672
21. D.B. Barnett E.L. Rugg S.L. Nahorski Direct evidence of two types of β-adrenoceptor binding site in lung tissues Nature 273 1978 166 168
22. K.P. Minneman L.R. Hegstrand P.B. Molinoff Simultaneous determination of beta-1 and beta-2 adrenergic receptors in tissues containing both receptor subtypes Mol. Pharmacol. 16 1979 34
23. M.C. Michel O.-E. Brodde P.A. Insel Peripheral adrenergic receptors in hypertension Hypertension 16 1990 107 120
24. 2-adrenoceptors in the human heart properties, functions and alterations in chronic heart failure Pharmacol. Rev. 43 1991 203 242
25. 2-adrenoreceptors in the human heart by chronic β-adrenoceptor antagonist treatment Br. J. Pharmacol. 94 1988 685 6902
26. A. Szentivanyi The beta-adrenergic theory of the atopic abnormality in bronchial asthma J. Allergy 42 1968 203 232
27. A. Szentivanyi O. Heim P. Schultze Changes in adrenoceptor densities in membranes of lung tissue and lymphocytes from patients with atopic disease Ann. N.Y. Acad. Sci. 332 1979 295 298
28. K. Kariman R.J. Lefkowitz Decrease beta-adrenergic receptor binding in lymphocytes from patients with bronchial asthma Clin. Res. 25 1977 503
29. S.M. Broosk K. McGowan I.L. Bernstein P. Altenau J. Peagler Relationship between numbers and beta-adrenergic receptors in lymphocytes and disease severity in asthma J. Allergy Clin. Immunol. 63 1979 401 406
30. S.P. Galant L. Duriseti S. Underwood P.A. Insel Decreased beta-adrenergic receptors on PMN leukocytes after adrenergic therapy N. Engl. J. Med. 199 1978 933 936
31. H. Meurs G.H. Koëter K. De Vries H.F. Kauffman The beta-adrenergic system and allergic bronchial asthma changes in lymphocyte beta-adrenergic receptor number and adenylate cyclase after an allergen-induced asthmatic attack J. Allergy Clin. Immunol. 70 1982 272 280
32. P.A. Insel S.I. Wasserman Asthma a disorder of adrenergic receptors? FASEB J. 4 1990 2732 2736
33. J.W. Harvey A.E. Tattersfield Airway response to salbutamol effect of regular salbutamol inhalation in normal, atopic and asthmatic subjects Thorax 37 1982 280 287
34. P.J. Barnes N.N. Pride Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects Br. J. Clin. Pharmacol. 15 1983 677 682
35. F.P. Nijkamp P.A. Henricks Receptors in airway disease. Beta-adrenoceptors in lung inflammation Am. Rev. Respir. Dis. 141 1990 S145 S150
36. H. Meurs J. Zaagsma Pharmacological and biochemical changes in airway smooth muscle in relation to bronchial hyperresponsiveness D.K. Agrawal R.G. Townley Inflammatory cells and mediators in bronchial asthma 1991 CRC Press Boca Raton, FL
37. D. Spina P.J. Rigby J.W. Paterson R.G. Goldie Autoradiographic localization of beta-adrenoceptors in asthmatic human lung Am. Rev. Respir. Dis. 140 1989 1410 1415
38. R.G. Goldie Receptors in asthmatic airways Am. Rev. Respir. Dis. 141 1990 S151 S156
39. C.J. Van Koppen J.F. De Miranda A.J. Beld C.L. Van Herwaarden J.W. Lammers C.A. Van Ginneken Beta-adrenoceptor binding and induced relaxation in airway smooth muscle from patients with chronic airflow obstruction Thorax 44 1989 28 35
40. R.K. Sharma P.K. Jeffery Airway beta-adrenoceptor number in cystic fibrosis and asthma Clin. Sci. 78 1990 409 417
41. E.B. Haddad J.C. Mak M.G. Belvisis M. Nishikawa J. Rousell P.J. Barnes Muscarinic and β-adrenergic receptor expression in peripheral lung from normal and asthmatic patients Am. J. Physiol. 270 1996 L947 L953
42. F. De Paermentier S.C. Cheetham M.R. Crompton C.L. Katona R.W. Horton Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims Brain Res. 525 1990 71 77
43. 3H]CGP 12177 Eur. J. Pharmacol. 167 1989 397 405
44. A. Pazos A. Probst J.M. Palacios Beta-adrenoceptor subtypes in the human brain autoradiographic localization Brain Res. 358 1985 324 328
45. J.N. Joyce N. Lexow S.J. Kim R. Artymyshyn S. Senzon D. Lawrence M.F. Cassanova J.E. Kleinman E.D. Bird A. Winokur Distribution of beta-adrenergic receptor subtypes in human post-mortem brain alterations in limbic regions of schizophrenics Synapse 10 1992 228 246
46. P. Valverius S. Borg M.R. Valverius P.L. Hoffman B. Tabakoff Beta-adrenergic receptor binding in brain of alcoholics Exp. Neurol. 105 1989 280 286
47. 2 receptors in prefrontal cortex and hippocampus J. Neurochem. 53 1989 1772 1781
48. C. Waeber M. Rigo G. Chinaglia A. Probst J.M. Palacios Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington’s chorea and Parkinson’s disease Synapse 8 1991 270 280
49. J. Sutin R. Griffith Beta-adrenergic receptor blockade suppresses glial scar formation Exp. Neurol. 120 1993 214 222
50. C. Hodges-Savola S.D. Robers J.R. Ghilardi D.R. Timm P.W. Mantyh Beta-adrenergic receptors regulate astrogliosis and cell proliferation in the central nervous system in vivo Glia 17 1996 52 62
51. D. Annane Médiation beta-adrenergique de la commande centrale de la ventilation mythe ou réaliteé? J. Toxicol. Clin. Exp. 11 1991 325 336
52. J.M. Maloteaux Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors Acta Neurol. Belg. 86 1986 61 129
53. 2 adrenergic receptors replicates propranolol’s suppression of the cerebral spread of an engram in mice Proc. Natl. Acad. Sci. U.S.A. 82 1985 7458 7461
54. E.A. Stone J.E. Platt Brain adrenergic receptors and resistance to stress Brain Res 237 1982 405 414
55. S. Garattini R. Samanin A critical evaluation of the current status of antidepressant drugs J. Psychiatr. Res. 18 1984 373 390
56. F. Okada Y. Tokumitsu Is the β-downregulation a prerequisitve of the antidepressant activity? J. Psychopharmacol. 8 1994 62 63
57. K.A. Jellingen Pathology of Parkinson’s disease changes other than the nigrostriatal pathway Mol. Chem. Neuropathol. 14 1991 153 197
58. P.M. Laduron Criteria for receptor sites in binding studies Biochem. Pharmacol. 33 1984 833 839
59. W.C. Eckelman The application of receptor theory to receptor binding and enzyme binding oncologic radiopharmaceuticals Nucl. Med. Biol. 21 1994 759 769
60. Van Waarde, A.; Elsinga, P.H.; Anthonio, R.L.; Visser, T.J.; Blanksma, P.K.; Visser, G.M.; Paans, A.M.J.; Vaalburg, W. Study of cardiac receptor ligands by positron emission tomograpy. In: Van der Wall E.E.; Blanksma P.K.; Niemeyer M.G.; Paans A.M.J., eds. Cardiac positron emission tomography. Dordrecht: Kluwer Academic Publishers; 1995:171–182.
61. R.E. Gibson W.C. Eckelman W.J. Rzeszotarski V. Jiang A. Mazaitis C. Paik T. Komai R.C. Reba Radiotracer localization by receptor-ligand interactions L.G. Colombetti Principles of radiopharmacology, Vol. 2 1979 CRC Press West Palm Beach, FL
62. M.P. Law Demonstration of the suitability of CGP 12177 for in vivo studies of β-adrenoceptors Br. J. Pharmacol. 109 1993 1101 1109
63. P.M. Laduron Stereospecificity in binding studies. A useful criterion though insufficient to prove the presence of receptors Biochem. Pharmacol. 37 1988 37 40
64. 3H]dihydroalprenolol to cardiac tissue Biochem. Pharmacol. 28 1979 1283 1288
65. M. Staehelin P. Simons K.A. Jaeggi N. Wigger CGP 12177, a hydrophilic beta-adrenoceptor radioligand, reveals high affinity binding of agonists to intact cells J. Biol. Chem. 258 1983 3496 3502
66. 11C]CGP 20712A) as a selective beta-1 adrenoceptor ligand for PET Nucl. Med. Biol. 21 1994 211 217
67. 11C-labelled β-adrenergic receptor ligands atenolol, metoprolol and propranolol Appl. Radiat. Isot. 7 1989 561 564
68. 11C]pindolol J. Labelled Comp. Radiopharm. 24 1987 227 232
69. 11C)-one (CGP 12177) J. Label. Comp. Radiopharm. 23 1986 565 567
70. 11C]carazolol, a radiotracer for the beta-adrenergic receptor Nucl. Med. Biol. 19 1992 563 569
71. 18F labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist J. Med. Chem. 37 1994 3219 3230
72. 18F]Fluoro-CGP 12388) for visualization of beta-adrenoceptors with positron emission tomography J. Med. Chem. 40 1997 3829 3835
73. Visser, T.J. Development of new muscarinic and β-adrenergic receptor radiopharmaceuticals for positron emission tomography. Ph.D. Thesis. University of Groningen, The Netherlands; 1997.
74. 2-adrenoceptor agonist J. Lab. Comp. Radiopharm. 40 1997 598 600
75. J. Delforge A. Syrota J.P. Lançon K. Nakajima C. Loc’h M. Janier Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177 and a new graphical method J. Nucl. Med. 32 1991 739 748
76. 11C]CGP 12177 to assess β-adrenergic receptor concentration in idiopathic dilated cardiomyopathy Circulation 87 1993 1169 1178
77. D.C. Lefroy R. De Silva L. Choudhury N.G. Uren T. Crake C.G. Rhodes Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy a study with positron emission tomography J. Am. Coll. Cardiol. 22 1993 1653 1660
78. 11C]CGP-12177 and PET J. Appl. Physiol. 75 1993 559 565
79. F. Qing C.G. Rhodes M.J. Hayes T. Krausz S.W. Fountain T. Jones J.M.B. Hughes In vivo quantification of human pulmonary beta-adrenoceptor density using PET comparison with in vitro radioligand binding J. Nucl. Med. 37 1996 1275 1281
80. J. Delforge Correction of a relationship that assesses beta-adrenergic receptor concentration with PET and carbon-11-CGP 12177 [letter] J. Nucl. Med. 35 1994 821
81. 11C]-CGP12177 metabolism in rat, dog and man using solid phase extraction and HPLC J. Lab. Comp. Radiopharm. 31 1992 518 520
82. A. Van Waarde R.L. Anthonio T.J. Visser P.H. Elsinga H. Posthumus A.M.A. Weemaes P.K. Blanksma G.M. Visser A.M.J. Paans W. Vaalburg Quantification of a carbon-11-labelled beta-adrenoceptor ligand, S-(-)CGP 12177, in plasma of humans and rats J. Chromatogr. B. 663 1995 361 369
83. L. Choudhury S. Guzetti C.D. Lefroy P. Nihoyannopoulos W.J. McKenna C.M. Oakley P.G. Camici Myocardial β-adrenoceptors and left ventricular function in hypertrophic cardiomyopathy Heart 75 1996 50 54
84. M. Schaefers D. Dutka C.G. Rhodes A.A. Lammertsma O. Schober P.G. Camici Myocardial pre- and postsynaptic autonomic dysfunction in patients with hypertrophic cardiomyopathy assessed by PET with [C-11]CGP 12177 and [C-11]hydroxyephedrine J. Nucl. Med. 37 1996 71P (abstract)
85. M. Schaefers H. Lerch T. Wichter C.G. Rhodes A.A. Lammertsma M. Borggrefe F. Hermannsen O. Schober G. Breitherdt P.G. Camici Cardiac autonomic dysfunction in patients with idiopathic ventricular tachycardia assessed by PET with [C-11]CGP 12177 and [C-11]hydroxyephedrine J. Nucl. Med. 38 1997 171P (abstract)
86. M.J. Hayes F. Qing C.G. Rhodes S.U. Rahman P.W. Ind S. Sriskandan T. Jones J.M. Hughes In vivo quantification of human pulmonary beta-adrenoceptors effect of beta-agonist therapy Am. J. Respir. Crit. Care Med. 154 1996 1277 1283
87. F. Qing S.U. Rahman C.G. Rhodes M.J. Hayes S. Sriskandan P.W. Ind T. Jones J.M.B. Hughes Pulmonary and cardiac beta-adrenoceptor density in vivo in asthmatic subjects Am J. Respir. Crit Care Med. 155 1997 1130 1134
88. F. Qing M.J. Hayes C.G. Rhodes T. Krausz S.W. Fountain M.M. Burke T. Jones J.M.B. Hughes Reduced β-adrenoceptor density in vivo in human lung tumors a preliminary study with positron emission tomography Thorax 51 1996 727 732
89. 11C]CGP 12177), as a preferred radioligand for β-adrenergic receptors Appl. Radiat. Isot. 42 1991 620 628
90. F. Aigbirhio V.W. Pike E. Francotte S.L. Waters B. Banfield K.A. Jaeggi A. Drake S-[1-(2,3-Diaminophenoxy)]-3′(N-t-butylamino)propan-2′-ol- Simplified asymmetric synthesis with CD and chiral HPLC analysis Tetrahedron: Asymmetry 3 1992 539 554
91. 18F]fluorocarazolol J. Nucl. Med. 38 1997 934 939
92. 18F]fluorocarazolol, ligands for the visualization of pulmonary β-adrenergic receptors with PET Nucl. Med. Biol. 23 1996 159 167
93. M.S. Berridge A.D. Nelson L. Zheng G.P. Leisure F. Miraldi Specfic beta-adrenergic receptor binding of carazolol measured with PET J. Nucl. Med. 35 1994 1665 1676
94. 18F]fluorocarazolol in intact rats reflects radioligand binding to β-adrenoceptors Eur. J. Pharmacol. 272 1995 159 168
95. 18F]fluorocarazolol for in vivo imaging and quantification of cerebral β-adrenoceptors. Eur. J. Pharmacol. (in press).
96. T.J. Visser A. Van Waarde T.W. Van der Mark J. Kraan P.H. Elsinga J. Pruim K. Ensing T. Jansen A.T.M. Willemsen E.J.F. Franssen G.M. Visser A.M.J. Paans W. Vaalburg Characterization of pulmonary and myocardial beta-adrenoceptors with S-1′-[fluorine-18]fluorocarazolol J. Nucl. Med. 38 1997 169 174
97. 18F]fluorometroprolol as a potential tracer for the visualization of β-adrenoceptors with PET Nucl. Med. Biol. 20 1993 637 642
98. Van Waarde, A.; Elsinga, P.H.; Doze, P.; Heldoorn, M.; Jaeggi, K.A.; Vaalburg, W. A novel β-adrenoceptor ligand for PET: evaluation in experimental animals. Eur. J. Pharmacol. (in press).
99. J.C. Mak B. Grandordy P.J. Barnes High affinity [3H]formoterol binding sites in lung characterization and autoradiographic mapping Eur. J. Pharmacol. 269 1994 35 41
100. F.J. Roux B. Grandordy J.S. Douglas Functional and binding characteristics of long-acting β2-agonists in lung and heart Am. J. Respir. Crit. Care Med. 153 1996 1489 1495
101. C.G. Löfdahl N. Svedmyr Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration Allergy 44 1989 264 271
102. K. Murase T. Mase H. Ida K. Takahashi M. Murakami Absolute configuration of four isomers of 3-formamido-4-hydroxy-α-[[N-(p-methoxy-α-methylphenethyl)amino]methyl]benzyl alcohol, a potent β-adrenoceptor stimulant Chem. Pharm. Bull. 26 1978 1123 1129
103. K. Murase T. Mase H. Ida K. Takahashi M. Murakami New β-adrenoceptor stimulants. Studies on 3-acylamino-4-hydroxy-α(N-substitutedaminomethyl)benzyl alcohols Chem. Pharm. Bull. 25 1977 1368 1377
104. J. Trofast K. Osterberg B.L. Kallstrom B. Waldeck Steric aspects of agonism and antagonism at beta-adrenoceptors synthesis of and pharmacological experiments with the enantiomers of formoterol and their diastereomers Chirality 3 1991 443 450
105. A.J. Bilski S.E. Halliday J.D. Fitzgerald J.L. Wale The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551) J. Cardiovasc. Pharmacol. 5 1983 430 437
106. H. Lemoine B. Ehle A.J. Kaumann Direct labelling of beta 2-adrenoceptors. Comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551 Naunyn Schmiedebergs Arch. Pharmacol. 331 1985 40 51
107. D.J. Dooley H. Bittiger N.C. Reymann CGP 10712 A a useful tool for quantitating beta 1- and beta 2-adrenoceptors Eur. J. Pharmacol. 130 1986 137 139
108. A.S. Manalan H.R. Besch A.M. Watanabe Characterization of [3H] (±) carazolol binding to β-adrenergic receptors. Application to study of β-adrenergic receptor subtypes in canine ventricular myocardium and lung Circ. Res. 49 1981 326 336
109. C. Becker H. Porzig Recovery of beta-adrenoceptors and cyclic AMP response after long term treatment of intact heart cells with beta-blockers Br. J. Pharmacol. 82 1984 745 755
110. T.H. Morris A.J. Kaumann Characteristics of 3H-(±)-carazolol binding to myocardial β-adrenoceptors Naunyn Schmiedebergs Arch. Pharmacol. 308 Suppl 1979 R33 (abstract)
111. H. Porzig C. Becker H. Reuter Competitive and non-competitive interactions between specific ligands and beta-adrenoceptors in living cardiac cells Naunyn Schmiedebergs Arch. Pharmacol. 321 1982 89 99
112. 1-adrenoceptor antagonist J. Lab. Comp. Radiopharm 40 1997 603 604
113. J.W. Daemmgen G. Engelhardt H. Pelzer Pharmacological properties of an extremely selective beta-1-adrenoceptor antagonist, 2-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-methoxy-4(3H)-quinazoline ([±] HX-CH 44 BS) Arzneimittelforschung 35 1985 383 390
114. C. Nanoff M. Freissmuth W. Schutz The role of a low beta-1 adrenoceptor selectivity of [3H]CGP 12177 for resolving subtype-selectivity of competitive ligands Naunyn Schmiedebergs Arch. Pharmacol. 336 1987 519 525
115. A. Van Waarde J.G. Meeder P.K. Blanksma O.-E. Brodde G.M. Visser P.H. Elsinga A.M.J. Paans W. Vaalburg K.I. Lie Suitability of CGP12177 and CGP26505 for quantitative imaging of β-adrenoceptors Nucl. Med. Biol. 19 1992 711 718